StockData
TransMedics Group, Inc. logo

TransMedics Group, Inc. (TMDX) stock

TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3029% below fair value
$93.91+1.70 (+1.84%)

Close on Nov 17, 2026Market cap $3.26BP/E 24.4Yield 0.00%

TransMedics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

TransMedics's price to book ratio was 6.2× on Nov 11, 2026, against 14.1× a year earlier. Over the last 5 years it ranged from 4.4× to 31.0×, with a median of 13.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20266.2×−5.5
2025Dec 31, 202511.7×+1.7
2024Dec 31, 202410.0×−10.4
2023Dec 29, 202320.4×+9.9
2022Dec 30, 202210.5×+3.7
2021Dec 31, 20216.8×+1.8
2020Dec 31, 20204.9×+2.2
2019Dec 31, 20192.8×–

More TransMedics figures

See a number that looks wrong?